Filing Details

Accession Number:
0001209191-17-046040
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-24 06:15:13
Reporting Period:
2017-07-20
Filing Date:
2017-07-24
Accepted Time:
2017-07-24 06:15:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1042074 Cymabay Therapeutics Inc. CBAY Pharmaceutical Preparations (2834) 943103561
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588861 Sujal Shah C/O Cymabay Therapeutics, Inc.
7999 Gateway Boulevard, Suite 130
Newark CA 94560
Interim President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-07-20 891 $7.29 75,891 No 4 P Direct
Common Stock Acquisiton 2017-07-20 400 $7.30 76,291 No 4 P Direct
Common Stock Acquisiton 2017-07-20 576 $7.31 76,867 No 4 P Direct
Common Stock Acquisiton 2017-07-20 100 $7.32 76,967 No 4 P Direct
Common Stock Acquisiton 2017-07-20 8,033 $7.35 85,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct